Kontafarma China Holdings Limited (HKG:1312)
Hong Kong
· Delayed Price · Currency is HKD 0.0290
0.00 (0.00%)
Apr 29, 2026, 3:55 PM HKT
Kontafarma China Holdings Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 914.71 | 897.52 | 809.11 | 894.06 | 803.27 | Upgrade
|
| Revenue Growth (YoY) | 1.92% | 10.93% | -9.50% | 11.30% | -20.40% | Upgrade
|
| Cost of Revenue | 401.07 | 381.36 | 337.82 | 387.84 | 407.09 | Upgrade
|
| Gross Profit | 513.64 | 516.16 | 471.29 | 506.22 | 396.18 | Upgrade
|
| Selling, General & Admin | 552.27 | 524.04 | 542.49 | 558.69 | 456.81 | Upgrade
|
| Other Operating Expenses | 8.37 | 34.63 | 20.75 | 29.11 | 34.33 | Upgrade
|
| Operating Expenses | 558.53 | 561.39 | 563.62 | 590.63 | 493.88 | Upgrade
|
| Operating Income | -44.9 | -45.23 | -92.33 | -84.41 | -97.71 | Upgrade
|
| Interest Expense | -10.76 | -13.39 | -15.25 | -23.28 | -33.61 | Upgrade
|
| Interest & Investment Income | 1.99 | 5.82 | 3.5 | 5.18 | 3.31 | Upgrade
|
| Currency Exchange Gain (Loss) | 16.33 | -7.82 | 5.13 | 4.02 | -2.9 | Upgrade
|
| Other Non Operating Income (Expenses) | 10.76 | 27.39 | 21.98 | 20.75 | 23.71 | Upgrade
|
| EBT Excluding Unusual Items | -26.58 | -33.24 | -76.97 | -77.74 | -107.2 | Upgrade
|
| Impairment of Goodwill | -111.54 | - | - | - | -46.36 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 15.24 | Upgrade
|
| Gain (Loss) on Sale of Assets | -3.8 | -0.03 | 109.77 | -1.9 | 50.23 | Upgrade
|
| Asset Writedown | -125.56 | -19.94 | -5.54 | - | - | Upgrade
|
| Other Unusual Items | -187.25 | -44.77 | -71.18 | -38.1 | 33.63 | Upgrade
|
| Pretax Income | -454.73 | -97.98 | -43.92 | -117.74 | -54.47 | Upgrade
|
| Income Tax Expense | 27.83 | 1.04 | 17.2 | -7.99 | 1.83 | Upgrade
|
| Earnings From Continuing Operations | -482.56 | -99.02 | -61.12 | -109.74 | -56.3 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | 43.33 | 32.67 | Upgrade
|
| Net Income to Company | -482.56 | -99.02 | -61.12 | -66.41 | -23.63 | Upgrade
|
| Minority Interest in Earnings | 54.71 | 23.48 | 32.27 | 24.87 | 8.58 | Upgrade
|
| Net Income | -427.85 | -75.54 | -28.84 | -41.55 | -15.05 | Upgrade
|
| Net Income to Common | -427.85 | -75.54 | -28.84 | -41.55 | -15.05 | Upgrade
|
| Shares Outstanding (Basic) | 5,579 | 5,579 | 5,579 | 5,579 | 5,579 | Upgrade
|
| Shares Outstanding (Diluted) | 5,579 | 5,579 | 5,579 | 5,579 | 5,579 | Upgrade
|
| EPS (Basic) | -0.08 | -0.01 | -0.01 | -0.01 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.08 | -0.01 | -0.01 | -0.01 | -0.00 | Upgrade
|
| Free Cash Flow | - | 33.41 | 13.2 | -53.84 | 7.88 | Upgrade
|
| Free Cash Flow Per Share | - | 0.01 | 0.00 | -0.01 | 0.00 | Upgrade
|
| Gross Margin | 56.15% | 57.51% | 58.25% | 56.62% | 49.32% | Upgrade
|
| Operating Margin | -4.91% | -5.04% | -11.41% | -9.44% | -12.16% | Upgrade
|
| Profit Margin | -46.77% | -8.42% | -3.56% | -4.65% | -1.87% | Upgrade
|
| Free Cash Flow Margin | - | 3.72% | 1.63% | -6.02% | 0.98% | Upgrade
|
| EBITDA | -10.67 | -11 | -49.83 | -30.21 | -40 | Upgrade
|
| EBITDA Margin | -1.17% | -1.23% | -6.16% | -3.38% | -4.98% | Upgrade
|
| D&A For EBITDA | 34.23 | 34.23 | 42.49 | 54.19 | 57.71 | Upgrade
|
| EBIT | -44.9 | -45.23 | -92.33 | -84.41 | -97.71 | Upgrade
|
| EBIT Margin | -4.91% | -5.04% | -11.41% | -9.44% | -12.16% | Upgrade
|
| Advertising Expenses | 446.46 | 427.6 | 419.1 | 428.68 | 313.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.